Jonathan I Lieber
CIK 1350090 · Chief Financial Officer · last filed 2026-02-23
Jonathan I Lieber is a Chief Financial Officer who has filed 32 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for RLYB, was dated Feb 23, 2026. Across all open-market trades the lifetime net is −$242.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.04M
5
32
-$242.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RLYB | Chief Financial Officer | 4,904 | $15.92 | $78.1K | $22.1K | 5 | 2026-02-23 |
| Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Director | 2,940 | $0.84 | $2.5K | $7.0K | 6 | 2024-02-22 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Chief Financial Officer | — | $0.39 | — | $0 | 3 | 2022-12-01 |
| RGEN | CFO | 15,000 | $130.59 | $1.96M | $0 | 1 | 2013-03-12 |
| Altus Pharmaceuticals Inc. (ALTU) Delisted | SVP, CFO and Treasurer | 0 | $10.12 | $0 | -$271.1K | 11 | 2008-05-27 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-23 | RLYB | Mixed | +1,711 | -$4.0K | EDGAR |
| 2025-02-19 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2024-02-22 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-16 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2023-03-16 | RLYB | Buy (P) | +5,000 | $26.1K | EDGAR |
| 2023-02-01 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Grant (A) | +1,440 | $0 | EDGAR |
| 2022-12-01 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-08-24 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-08 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Buy (P) | +37,500 | $7.0K | EDGAR |